RenovoRx, Inc. ("RenovoRx" or the "Company") , a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, highlighted its ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...
RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...
RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...
The Punch Newspapers on MSN9h
Cardiovascular diseases in smokers and interventional treatments"Smokers face an elevated risk of developing an array of cardiovascular diseases, and many require advanced interventional ...
The recently approved device simplifies operator manipulations by loading a balloon and filter onto the stent.
Functional recovery at 90 days was lower in the balloon-guided catheter group versus the conventional catheter group. 2.
Hosted on MSN15d
Balloon Angioplasty: Everything You Need to KnowBalloon angioplasty is an interventional technique in which a specially equipped catheter is inserted into ... are multiple blockages or chronic total occlusion (in which a vessel is completely ...
Navigation Menu Toggle navigation Sign in Product ...
Before using the FiberNet EPD, we performed renal stenting with other EPD and have published a series of 139 RAS treated in 119 patients with occlusion balloon (46 procedures) and other filters ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback